Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis

Journal of Molecular Biology

Volumn 335, Issue 3, 2004, Pages 833-842

  Williams, Angela D ^a   Portelius, Erik ^b   Kheterpal, Indu ^a   Guo, Jun Tao ^c   Cook, Kelsey D ^b   Xu, Ying ^c   Wetzel, Ronald ^a  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c NONE   (United States)

Author keywords

Amyloid; Critical concentration; Hydrogen exchange; Proline; ThT, thioflavin T; Turns; WT, wild type

Indexed keywords

AMYLOID BETA PROTEIN; PEPTIDE FRAGMENT; PROLINE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE MAPPING; GENE SEQUENCE; HYDROGEN BOND; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN SECONDARY STRUCTURE; THERMODYNAMICS; WILD TYPE; AMINO ACID SUBSTITUTION; CHEMISTRY; ELECTRON MICROSCOPY; GENETICS; HUMAN; KINETICS; SITE DIRECTED MUTAGENESIS;

AMINO ACID SUBSTITUTION; AMYLOID BETA-PROTEIN; HUMANS; KINETICS; MICROSCOPY, ELECTRON; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROLINE; PROTEIN STRUCTURE, SECONDARY;

EID: 1542600164     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2003.11.008     Document Type: Article

References (54)

1. Falk R.H., Comenzo R.L., Skinner M. The systemic amyloidoses. N. Engl. J. Med. 337:1997;898-909.
2. Martin J.B. Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340:1999;1970-1980.
3. Merlini G., Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med. 349:2003;583-596.
4. Kelly J.W. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:1998;101-106.
5. Wetzel R. Protein aggregation in vivo: bacterial inclusion bodies and mammalian amyloid. Ahern T.J., Manning M.C. Stability of Protein Pharmaceuticals: In Vivo Pathways of Degradation and Strategies for Protein Stabilization. 1992;43-88 Plenum Press, New York.
6. Wetzel R. Mutations and off-pathway aggregation. Trends Biotechnol. 12:1994;193-198.
7. King J., Haase-Pettingell C., Robinson A.S., Speed M., Mitraki A. Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates. FASEB J. 10:1996;57-66.
8. Kopito R.R., Ron D. Conformational disease. Nature Cell. Biol. 2:2000;E207-E209.
9. Fandrich M., Fletcher M.A., Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature. 410:2001;165-166.
10. Serpell L.C., Smith J.M. Direct visualization of the beta-sheet structure of synthetic Alzheimer's amyloid. J. Mol. Biol. 299:2000;225-231.
11. Sunde M., Blake C. The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Advan. Protein Chem. 50:1997;123-159.
12. Lakdawala A.S., Morgan D.M., Liotta D.C., Lynn D.G., Snyder J.P. Dynamics and fluidity of amyloid fibrils: a model of fibrous protein aggregates. J. Am. Chem. Soc. 124:2002;150-151.
13. Petkova A.T., Ishii Y., Balbach J.J., Antzutkin O.N., Leapman R.D., Delaglio F., Tycko R. A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR. Proc. Natl Acad. Sci. USA. 99:2002;16742-16747.
14. Balbach J.J., Ishii Y., Antzutkin O.N., Leapman R.D., Rizzo N.W., Dyda F., et al. Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR. Biochemistry. 39:2000;13748-13759.
15. Sunde M., Serpell L.C., Bartlam M., Fraser P.E., Pepys M.B., Blake C.C. Common core structure of amyloid fibrils by synchrotron X-ray diffraction. J. Mol. Biol. 273:1997;729-739.
16. Jimenez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C.M., Sunde M., Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18:1999;815-821.
17. Balbirnie M., Grothe R., Eisenberg D.S. An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid. Proc. Natl Acad. Sci. USA. 98:2001;2375-2380.
18. Sikorski P., Atkins E.D., Serpell L.C. Structure and texture of fibrous crystals formed by Alzheimer's abeta(11-25) peptide fragment. Structure (Camb). 11:2003;915-926.
19. Lazo N.D., Downing D.T. Amyloid fibrils may be assembled from beta-helical protofibrils. Biochemistry. 37:1998;1731-1735.
20. Jenkins J., Pickersgill R. The architecture of parallel beta-helices and related folds. Prog. Biophys. Mol. Biol. 77:2001;111-175.
21. Wille H., Michelitsch M.D., Guenebaut V., Supattapone S., Serban A., Cohen F.E., et al. Structural studies of the scrapie prion protein by electron crystallography. Proc. Natl Acad. Sci. USA. 99:2002;3563-3568.
22. Wetzel R. Ideas of order for amyloid fibril structure. Structure. 10:2002;1031-1036.
23. Jimenez J.L., Nettleton E.J., Bouchard M., Robinson C.V., Dobson C.M., Saibil H.R. The protofilament structure of insulin amyloid fibrils. Proc. Natl Acad. Sci. USA. 99:2002;9196-9201.
24. Stevens F.J., Myatt E.A., Chang C.H., Westholm F.A., Eulitz M., Weiss D.T., et al. A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. Biochemistry. 34:1995;10697-10702.
25. Elam J.S., Taylor A.B., Strange R., Antonyuk S., Doucette P.A., Rodriguez J.A., et al. Amyloid-like filaments and water-filled nanotubes formed by SOD1 mutant proteins linked to familial ALS. Nature Struct. Biol. 10:2003;461-467.
26. Kheterpal I., Zhou S., Cook K.D., Wetzel R. A β amyloid fibrils possess a core structure highly resistant to hydrogen exchange. Proc. Natl Acad. Sci. USA. 97:2000;13597-13601.
27. Kheterpal I., Wetzel R., Cook K. Enhanced correction methods for hydrogen exchange-mass spectrometry studies of amyloid fibrils. Protein Sci. 12:2003;635-643.
28. Kheterpal I., Williams A., Murphy C., Bledsoe B., Wetzel R. Structural features of the Aβ amyloid fibril elucidated by limited proteolysis. Biochemistry. 40:2001;11757-11767.
29. Torok M., Milton S., Kayed R., Wu P., McIntire T., Glabe C.G., Langen R. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol. Chem. 277:2002;40810-40815.
30. Wood S.J., Wetzel R., Martin J.D., Hurle M.R. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide β/A4. Biochemistry. 34:1995;724-730.
31. Chou P.Y., Fasman G.D. Empirical predictions of protein conformation. Annu. Rev. Biochem. 47:1978;251-276.
32. Lifson S., Sander C. Antiparallel and parallel beta-strands differ in amino acid residue preferences. Nature. 282:1979;109-111.
33. Chothia C., Janin J. Relative orientation of close-packed b-pleated sheets in proteins. Proc. Natl Acad. Sci. USA. 78:1981;4146-4150.
34. Kim C.A., Berg J.M. Thermodynamic β-sheet propensities measured using a zinc-finger host peptide. Nature. 362:1993;267-270.
35. Minor J., Daniel L., Kim P.S. Context is a major determinant of β-sheet propensity. Nature. 371:1994;264-267.
36. Smith C.K., Withka J.M., Regan L. A thermodynamic scale for the β-sheet forming tendencies of the amino acids. Biochemistry. 33:1994;5510-5517.
37. Richardson J.S., Richardson D.C. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc. Natl Acad. Sci. USA. 99:2002;2754-2759.
38. Moriarty D.F., Raleigh D.P. Effects of sequential proline substitutions on amyloid formation by human amylin20-29. Biochemistry. 38:1999;1811-1818.
39. Thakur A., Wetzel R. Mutational analysis of the structural organization of polyglutamine aggregates. Proc. Natl Acad. Sci. USA. 99:2002;17014-17019.
40. Morimoto A., Irie K., Murakami K., Ohigashi H., Shindo M., Nagao M., et al. Aggregation and neurotoxicity of mutant amyloid beta (Abeta) peptides with proline replacement: importance of turn formation at positions 22 and 23. Biochem. Biophys. Res. Commun. 295:2002;306-311.
41. Harper J.D., Lansbury P.T. Jr. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66:1997;385-407.
42. Nilsberth C., Westlind-Danielsson A., Eckman C.B., Condron M.M., Axelman K., Forsell C., et al. The "Arctic" APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nature Neurosci. 4:2001;887-893.
43. Pakula A.A., Sauer R.T. Reverse hydrophobic effects relieved by amino-acid substitutions at a protein surface. Nature. 344:1990;363-364.
44. Wood S.J., Maleeff B., Hart T., Wetzel R. Physical, morphological and functional differences between pH 5.8 and 7.4 aggregates of the Alzheimer's peptide Aβ J. Mol. Biol. 256:1996;870-877.
45. O'Nuallain B., Wetzel R. Conformational antibodies recognizing a generic amyloid fibril epitope. Proc. Natl Acad. Sci. USA. 99:2002;1485-1490.
46. Chiti F., Stefani M., Taddei N., Ramponi G., Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature. 424:2003;805-808.
47. Jarrett J.T., Berger E.P., Lansbury P.T. Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
48. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 275:1997;630-631.
49. Tjernberg L.O., Callaway D.J., Tjernberg A., Hahne S., Lilliehook C., Terenius L., et al. A molecular model of Alzheimer amyloid beta-peptide fibril formation. J. Biol. Chem. 274:1999;12619-12625.
50. Huang T.H., Fraser P.E., Chakrabartty A. Fibrillogenesis of Alzheimer Abeta peptides studied by fluorescence energy transfer. J. Mol. Biol. 269:1997;214-224.
51. Holm L., Sander C. Mapping the protein universe. Science. 273:1996;595-603.
52. Murzin A.G., Brenner S.E., Hubbard T., Chothia C. SCOP: a structural classification of proteins database for the investigation of sequences and structures. J. Mol. Biol. 247:1995;536-540.
53. Frishman D., Argos P. Knowledge-based protein secondary structure assignment. Proteins Struct. Funct. Genet. 23:1995;566-579.
54. Levitt M. Conformational preferences of amino acids in globular proteins. Biochemistry. 17:1978;4277-4285.